Эта страница была переведена автоматически, точность перевода не гарантируется. Пожалуйста, обратитесь к английской версии для исходного текста.

Multitarget HD-tDCS and Spatial Navigation Memory in Schizophrenia (HD-tDCS-SCZ)

10 ноября 2026 г. обновлено: School of Psychology, Northwest Normal University

Effects of Multitarget High-Definition Transcranial Direct Current Stimulation and Learning Strategy on Spatial Navigation Memory in Patients With Schizophrenia: A Randomized Sham-Controlled Study

This study investigated whether multitarget high-definition transcranial direct current stimulation (HD-tDCS), combined with cognitive learning strategies, could improve temporal order memory during spatial navigation in patients with schizophrenia.

Schizophrenia is frequently associated with cognitive impairments, including difficulties remembering the order of events and navigating unfamiliar environments. This study examined whether noninvasive electrical brain stimulation could enhance the benefits of repeated memory testing compared with repeated studying.

In this randomized, single-blind, sham-controlled study, 59 hospitalized patients with schizophrenia were assigned to receive either active or sham HD-tDCS while completing a spatial navigation learning task. Both groups performed forward-testing and restudy conditions. Active stimulation was delivered for 20 minutes, and spatial navigation learning lasted approximately 45 minutes.

Spatial navigation memory was evaluated using landmark-order recall accuracy. Resting-state functional near-infrared spectroscopy (fNIRS) was performed before and after the intervention to examine changes in functional connectivity between prefrontal and parietal brain regions.

The study aimed to determine whether multitarget HD-tDCS could improve spatial navigation memory, enhance the benefits of forward testing, and influence functional connectivity in brain networks involved in cognitive control and spatial attention.

Обзор исследования

Статус

Завершенный

Условия

Вмешательство/лечение

Подробное описание

  1. Background and Rationale:

    Cognitive impairment is a core feature of schizophrenia and contributes to difficulties in daily functioning. Temporal order memory, which refers to the ability to remember the sequence of events, plays an important role in spatial navigation and the organization of everyday experiences. Patients with schizophrenia frequently demonstrate impairments in temporal processing, episodic memory, and spatial navigation.

    The dorsolateral prefrontal cortex (DLPFC) and inferior parietal lobule (IPL) are involved in cognitive control, working memory, spatial attention, and contextual updating. Altered functional interactions between these regions may contribute to cognitive difficulties in schizophrenia.

    High-definition transcranial direct current stimulation (HD-tDCS) is a noninvasive brain stimulation technique that can modulate cortical activity. Multitarget HD-tDCS may influence multiple cortical regions involved in distributed cognitive networks. Combining brain stimulation with cognitive strategies may provide an approach to improving memory performance.

    Forward testing is a learning strategy in which previously studied information is tested before subsequent information is learned. This strategy may facilitate new learning by reducing interference and improving contextual differentiation. The present study investigated whether multitarget HD-tDCS could enhance the effects of forward testing on spatial navigation memory.

  2. Study Design

    This study used a randomized, single-blind, sham-controlled, parallel-group design. Sixty hospitalized patients diagnosed with schizophrenia according to DSM-5 criteria were assigned to either an active HD-tDCS group or a sham stimulation group, with 30 participants allocated to each group.

    Both groups completed the same spatial navigation learning task, including forward-testing and restudy conditions.

  3. Intervention:

    Multitarget HD-tDCS was administered using a Starstim 32 stimulation system (Neuroelectrics, Spain). Stimulation was directed toward dorsolateral prefrontal and parietal cortical regions.

    Participants in the active stimulation group received 2.0 mA stimulation for 20 minutes while performing the spatial navigation learning task. Participants in the sham group underwent the same electrode setup but received only brief current stimulation periods at the beginning and end of the session.

  4. Spatial Navigation Task:

    Participants completed a spatial navigation task involving four routes presented in video format. The task included two learning strategies.

    In the forward-testing condition, participants completed interim memory tests after studying route information. In the restudy condition, participants repeatedly studied route information without equivalent interim testing.

    Route materials and presentation order were counterbalanced across conditions. Spatial navigation performance was assessed using landmark-order recall accuracy during the final route test.

  5. Neuroimaging Assessment:

    Resting-state functional near-infrared spectroscopy (fNIRS) was used to investigate changes in cortical functional connectivity associated with the intervention.

    Eight-minute resting-state fNIRS recordings were obtained before and after the spatial navigation task. The recordings measured changes in oxygenated and deoxygenated hemoglobin concentrations.

    Functional connectivity was estimated between regions associated with the DLPFC and IPL. Changes in functional connectivity were examined to explore potential relationships between brain network activity and spatial navigation performance.

  6. Study Objectives:

The study investigated whether multitarget HD-tDCS combined with cognitive learning strategies could influence immediate temporal order memory during spatial navigation in patients with schizophrenia.

Additional objectives included examining intervention-related changes in resting-state frontoparietal functional connectivity and exploring associations between connectivity measures, cognitive performance, and clinical characteristics.

Тип исследования

Интервенционный

Регистрация (Действительный)

60

Фаза

  • Непригодный

Контакты и местонахождение

В этом разделе приведены контактные данные лиц, проводящих исследование, и информация о том, где проводится это исследование.

Места учебы

    • Gansu
      • Lanzhou, Gansu, Китай
        • The Third People's Hospital of Lanzhou

Критерии участия

Исследователи ищут людей, которые соответствуют определенному описанию, называемому критериям приемлемости. Некоторыми примерами этих критериев являются общее состояние здоровья человека или предшествующее лечение.

Критерии приемлемости

Возраст, подходящий для обучения

От 17 лет до 62 года (Ребенок, Взрослый)

Принимает здоровых добровольцев

Нет

Полы, имеющие право на обучение

Все

Описание

Inclusion Criteria:

  • Diagnosis of schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Duration of illness of at least 1 year.

Predominantly negative symptoms based on clinical assessment.

Total Positive and Negative Syndrome Scale (PANSS) score greater than 70.

Stable antipsychotic medication for at least 8 weeks.

Montreal Cognitive Assessment (MoCA) score between 10 and 26.

Exclusion Criteria:

  • Substance abuse, excluding caffeine and tobacco use.

Presence of other psychiatric disorders.

Contraindications to transcranial electrical stimulation, including intracranial implants or a history of epilepsy.

Pregnancy or breastfeeding.

Учебный план

В этом разделе представлена ​​подробная информация о плане исследования, в том числе о том, как планируется исследование и что оно измеряет.

Как устроено исследование?

Детали дизайна

  • Основная цель: Уход
  • Распределение: Рандомизированный
  • Интервенционная модель: Параллельное назначение
  • Маскировка: Одинокий

Оружие и интервенции

Группа участников / Армия
Вмешательство/лечение
Экспериментальный: Active Multitarget HD-tDCS

Participants received active multitarget high-definition transcranial direct current stimulation (HD-tDCS) at 2.0 mA for 20 minutes while completing spatial navigation learning tasks involving forward-testing and restudy conditions.

Multitarget high-definition transcranial direct current stimulation was administered using a Starstim 32 system (Neuroelectrics, Spain). Active stimulation was delivered at 2.0 mA for 20 minutes, concurrently with spatial navigation learning tasks. Stimulation targeted dorsolateral prefrontal and parietal cortical regions.

Фальшивый компаратор: Sham HD-tDCS

Participants received sham HD-tDCS using the same electrode montage as the active group, with brief current delivery and approximately 30-second ramping periods at the beginning and end of stimulation, without sustained stimulation. Participants completed the same spatial navigation learning tasks involving forward-testing and restudy conditions.

Sham stimulation was administered using the same Starstim 32 system and electrode montage as the active-stimulation condition. Brief current application, including approximately 30-second ramping periods at the beginning and end of the session, was used without sustained stimulation. Participants performed the same spatial navigation learning tasks as those in the active-stimulation group.

Что измеряет исследование?

Первичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
Landmark-Order Recall Accuracy
Временное ограничение: Immediately following the spatial navigation learning task (approximately 45 minutes after task initiation).

Landmark-order recall accuracy was assessed during the final test of the spatial navigation task under forward-testing and restudy learning conditions. Accuracy was calculated as the proportion of correctly recalled landmark-order information, with scores ranging from 0 to 1. Higher scores indicate better temporal order memory performance.

Immediately following the spatial navigation learning task (approximately 45 minutes after task initiation).

Вторичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
Change in Resting-State DLPFC-IPL Functional Connectivity (HbO)
Временное ограничение: Baseline and immediately after the intervention (8-minute resting-state recordings at each assessment).

Resting-state functional connectivity between dorsolateral prefrontal cortex (DLPFC)-associated and inferior parietal lobule (IPL)-associated regions was assessed using functional near-infrared spectroscopy (fNIRS). Pearson correlation coefficients between predefined regions of interest were Fisher z-transformed and averaged. The outcome was calculated as post-intervention minus pre-intervention connectivity using oxygenated hemoglobin (HbO) signals.

Baseline and immediately after the intervention (8-minute resting-state recordings at each assessment).
Change in Resting-State DLPFC-IPL Functional Connectivity (HbR)
Временное ограничение: Baseline and immediately after the intervention (8-minute resting-state recordings at each assessment).

Resting-state functional connectivity between dorsolateral prefrontal cortex (DLPFC)-associated and inferior parietal lobule (IPL)-associated regions was assessed using functional near-infrared spectroscopy (fNIRS). Pearson correlation coefficients between predefined regions of interest were Fisher z-transformed and averaged. The outcome was calculated as post-intervention minus pre-intervention connectivity using deoxygenated hemoglobin (HbR) signals.

Baseline and immediately after the intervention (8-minute resting-state recordings at each assessment).

Соавторы и исследователи

Здесь вы найдете людей и организации, участвующие в этом исследовании.

Спонсор

Соавторы

Следователи

  • Главный следователь: Wenxi Su, PhD, School of Psychology, Northwest Normal University

Публикации и полезные ссылки

Лицо, ответственное за внесение сведений об исследовании, добровольно предоставляет эти публикации. Это может быть что угодно, связанное с исследованием.

Даты записи исследования

Эти даты отслеживают ход отправки отчетов об исследованиях и сводных результатов на сайт ClinicalTrials.gov. Записи исследований и сообщаемые результаты проверяются Национальной медицинской библиотекой (NLM), чтобы убедиться, что они соответствуют определенным стандартам контроля качества, прежде чем публиковать их на общедоступном веб-сайте.

Изучение основных дат

Начало исследования (Действительный)

9 января 2026 г.

Первичное завершение (Действительный)

20 мая 2026 г.

Завершение исследования (Действительный)

31 мая 2026 г.

Даты регистрации исследования

Первый отправленный

10 ноября 2026 г.

Впервые представлено, что соответствует критериям контроля качества

10 ноября 2026 г.

Первый опубликованный (Действительный)

16 ноября 2026 г.

Обновления учебных записей

Последнее опубликованное обновление (Действительный)

16 ноября 2026 г.

Последнее отправленное обновление, отвечающее критериям контроля качества

10 ноября 2026 г.

Последняя проверка

1 ноября 2026 г.

Дополнительная информация

Термины, связанные с этим исследованием

Другие идентификационные номера исследования

  • 20261008
  • 32560207 (Другой номер гранта/финансирования: National Natural Science Foundation of China)
  • 2026CXZX-272 (Другой номер гранта/финансирования: Gansu Provincial University Graduate Innovation Star Project)
  • GSJKKY2025-19 (Другой номер гранта/финансирования: Gansu Provincial Disease Prevention and Control Research Program)
  • GSWSQN2025-25 (Другой номер гранта/финансирования: Gansu Provincial Health Research Project)

Планирование данных отдельных участников (IPD)

Планируете делиться данными об отдельных участниках (IPD)?

НЕТ

Описание плана IPD

Individual participant data will not be shared because the dataset contains sensitive psychiatric and clinical information. The study team has no current plan to make individual-level data available to external researchers.

Информация о лекарствах и устройствах, исследовательские документы

Изучает лекарственный продукт, регулируемый FDA США.

Нет

Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.

Нет

Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .